Rho site logo

Strategies for Analgesic Development and the New FDA Guidance for Analgesic Indications

webinar-callout.pngCDER recently issued an updated draft guidance for Analgesic Indications. In this webinar, Brett Gordon and Ben Vaughn provide a high-level review of the agency’s guidance, offer strategies for analgesic product development and share experiences with PROs and paper vs. tablet collection.